BioCentury
ARTICLE | Clinical News

Embeda morphine/naltrexone regulatory update

November 11, 2013 8:00 AM UTC

Pfizer said FDA approved an update to the manufacturing process of Embeda morphine/naltrexone for managing pain. The process addresses the stability issue that led to the drug's U.S. recall in March 2...